Dr. Meghraj Ingle reminds nonalcoholic fatty liver disease (NAFLD), which got no noticeable symptoms in its early stages, can ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...

16-year-old Indian youth, Aditya Kumar Jha from VIBGYOR High School, Mumbai, has established himself as a force to be ...

Fatty liver is a health crisis that occurs when more than 5% of fat builds up in the liver due to various behavioural and ...

At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a ...

The researchers found that the cause behind prevalence of fatty liver disease among IT employees is attributed to the ...

The global human liver model market, valued at $1.34 billion in 2024, is projected to grow at a CAGR of 14.04% through 2030, ...

Fatty liver disease is not just linked to alcohol and taking proactive steps, you can effectively manage and potentially ...

Madrigal Pharmaceuticals (MDGL) reported positive two-year results from the open-label compensated MASH cirrhosis arm of the Phase 3 ...